Form 4 holding
CFO
Aridis Pharmaceuticals, Inc.
- Security class
- Stock Options
- Shares / value
- 84,575
- Estimated value
- Report date
- 04 May 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Fred Kurland - CFO at Aridis Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Cfo
- Issuer ticker
- ARDS
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Fred Kurland since 28 Aug 2025
Reported holdings for Fred Kurland in Aridis Pharmaceuticals, Inc.
Form 4 holding
CFO
Aridis Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 4,000
- Estimated value
- Report date
- 05 Jun 2023
- Price
- Ownership
- Direct
Form 4 holding
CFO
Aridis Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 4,000
- Estimated value
- Report date
- 05 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Fred Kurland in Aridis Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.